Logo image of ACO-X.CA

ATCO LTD -CLASS I (ACO-X.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:ACO-X - CA0467894006 - Common Stock

55.57 CAD
-0.07 (-0.13%)
Last: 12/18/2025, 7:00:00 PM
Fundamental Rating

5

Overall ACO-X gets a fundamental rating of 5 out of 10. We evaluated ACO-X against 21 industry peers in the Multi-Utilities industry. Both the profitability and the financial health of ACO-X get a neutral evaluation. Nothing too spectacular is happening here. ACO-X is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ACO-X had positive earnings in the past year.
ACO-X had a positive operating cash flow in the past year.
In the past 5 years ACO-X has always been profitable.
Each year in the past 5 years ACO-X had a positive operating cash flow.
ACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFACO-X.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

ACO-X has a Return On Assets (1.55%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 9.08%, ACO-X belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
The Return On Invested Capital of ACO-X (3.73%) is worse than 71.43% of its industry peers.
ACO-X had an Average Return On Invested Capital over the past 3 years of 3.92%. This is in line with the industry average of 3.74%.
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROIC 3.73%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ACO-X.CA Yearly ROA, ROE, ROICACO-X.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

ACO-X has a Profit Margin (8.38%) which is in line with its industry peers.
ACO-X's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 24.56%, ACO-X perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
In the last couple of years the Operating Margin of ACO-X has declined.
ACO-X has a Gross Margin (74.90%) which is in line with its industry peers.
ACO-X's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
ACO-X.CA Yearly Profit, Operating, Gross MarginsACO-X.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACO-X is destroying value.
The number of shares outstanding for ACO-X remains at a similar level compared to 1 year ago.
ACO-X has less shares outstanding than it did 5 years ago.
The debt/assets ratio for ACO-X is higher compared to a year ago.
ACO-X.CA Yearly Shares OutstandingACO-X.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ACO-X.CA Yearly Total Debt VS Total AssetsACO-X.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 0.77, we must say that ACO-X is in the distress zone and has some risk of bankruptcy.
ACO-X has a Altman-Z score of 0.77. This is amongst the best in the industry. ACO-X outperforms 80.95% of its industry peers.
ACO-X has a debt to FCF ratio of 27.90. This is a negative value and a sign of low solvency as ACO-X would need 27.90 years to pay back of all of its debts.
ACO-X's Debt to FCF ratio of 27.90 is amongst the best of the industry. ACO-X outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 2.64 is on the high side and indicates that ACO-X has dependencies on debt financing.
ACO-X has a Debt to Equity ratio of 2.64. This is in the lower half of the industry: ACO-X underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Altman-Z 0.77
ROIC/WACC0.74
WACC5.06%
ACO-X.CA Yearly LT Debt VS Equity VS FCFACO-X.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.81 indicates that ACO-X should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.81, ACO-X belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ACO-X has a Quick Ratio of 1.66. This is a normal value and indicates that ACO-X is financially healthy and should not expect problems in meeting its short term obligations.
ACO-X's Quick ratio of 1.66 is amongst the best of the industry. ACO-X outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.66
ACO-X.CA Yearly Current Assets VS Current LiabilitesACO-X.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.19% over the past year.
The Earnings Per Share has been growing slightly by 6.10% on average over the past years.
Looking at the last year, ACO-X shows a small growth in Revenue. The Revenue has grown by 7.75% in the last year.
The Revenue has been growing slightly by 0.98% on average over the past years.
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%

3.2 Future

The Earnings Per Share is expected to grow by 5.04% on average over the next years.
The Revenue is expected to grow by 0.61% on average over the next years.
EPS Next Y9.29%
EPS Next 2Y5.14%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue Next Year-5%
Revenue Next 2Y-1%
Revenue Next 3Y0.61%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACO-X.CA Yearly Revenue VS EstimatesACO-X.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ACO-X.CA Yearly EPS VS EstimatesACO-X.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

ACO-X is valuated correctly with a Price/Earnings ratio of 12.24.
Compared to the rest of the industry, the Price/Earnings ratio of ACO-X is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.26. ACO-X is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 11.72, the valuation of ACO-X can be described as very reasonable.
61.90% of the companies in the same industry are more expensive than ACO-X, based on the Price/Forward Earnings ratio.
ACO-X is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.24
Fwd PE 11.72
ACO-X.CA Price Earnings VS Forward Price EarningsACO-X.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACO-X is valued a bit cheaper than 76.19% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACO-X indicates a somewhat cheap valuation: ACO-X is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.43
EV/EBITDA 8.32
ACO-X.CA Per share dataACO-X.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

ACO-X's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.32
PEG (5Y)2.01
EPS Next 2Y5.14%
EPS Next 3Y5.04%

6

5. Dividend

5.1 Amount

ACO-X has a Yearly Dividend Yield of 3.82%.
Compared to an average industry Dividend Yield of 4.90, ACO-X's dividend is way lower than its industry peers. On top of this 95.24% of the companies listed in the same industry pay a better dividend than ACO-X!
ACO-X's Dividend Yield is rather good when compared to the S&P500 average which is at 1.87.
Industry RankSector Rank
Dividend Yield 3.82%

5.2 History

The dividend of ACO-X has a limited annual growth rate of 3.93%.
ACO-X has been paying a dividend for at least 10 years, so it has a reliable track record.
ACO-X has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.93%
Div Incr Years31
Div Non Decr Years34
ACO-X.CA Yearly Dividends per shareACO-X.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACO-X pays out 52.20% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of ACO-X is growing, but earnings are growing more, so the dividend growth is sustainable.
DP52.2%
EPS Next 2Y5.14%
EPS Next 3Y5.04%
ACO-X.CA Yearly Income VS Free CF VS DividendACO-X.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M
ACO-X.CA Dividend Payout.ACO-X.CA Dividend Payout, showing the Payout Ratio.ACO-X.CA Dividend Payout.PayoutRetained Earnings

ATCO LTD -CLASS I

TSX:ACO-X (12/18/2025, 7:00:00 PM)

55.57

-0.07 (-0.13%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)02-25 2026-02-25
Inst Owners28.28%
Inst Owner ChangeN/A
Ins Owners0.68%
Ins Owner ChangeN/A
Market Cap6.23B
Revenue(TTM)5.14B
Net Income(TTM)431.00M
Analysts78.57
Price Target59.5 (7.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.82%
Yearly Dividend1.96
Dividend Growth(5Y)3.93%
DP52.2%
Div Incr Years31
Div Non Decr Years34
Ex-Date12-04 2025-12-04 (0.5045)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.14%
Min EPS beat(2)-3.78%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)2.22%
Min EPS beat(4)-3.78%
Max EPS beat(4)8.05%
EPS beat(8)7
Avg EPS beat(8)4.37%
EPS beat(12)9
Avg EPS beat(12)2.66%
EPS beat(16)12
Avg EPS beat(16)4.06%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-17.7%
Max Revenue beat(2)-1.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.73%
Min Revenue beat(4)-18.52%
Max Revenue beat(4)-0.7%
Revenue beat(8)0
Avg Revenue beat(8)-11.91%
Revenue beat(12)0
Avg Revenue beat(12)-10.29%
Revenue beat(16)1
Avg Revenue beat(16)-9.26%
PT rev (1m)3.64%
PT rev (3m)4.7%
EPS NQ rev (1m)0.27%
EPS NQ rev (3m)0.27%
EPS NY rev (1m)0.93%
EPS NY rev (3m)1.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.42%
Valuation
Industry RankSector Rank
PE 12.24
Fwd PE 11.72
P/S 1.21
P/FCF 13.43
P/OCF 2.55
P/B 1.31
P/tB 1.84
EV/EBITDA 8.32
EPS(TTM)4.54
EY8.17%
EPS(NY)4.74
Fwd EY8.53%
FCF(TTM)4.14
FCFY7.45%
OCF(TTM)21.76
OCFY39.15%
SpS45.88
BVpS42.35
TBVpS30.16
PEG (NY)1.32
PEG (5Y)2.01
Graham Number65.77
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROCE 4.79%
ROIC 3.73%
ROICexc 3.92%
ROICexgc 4.15%
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
FCFM 9.02%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ROICexc(3y)4.06%
ROICexc(5y)3.97%
ROICexgc(3y)4.27%
ROICexgc(5y)4.16%
ROCE(3y)5.04%
ROCE(5y)4.9%
ROICexgc growth 3Y1.58%
ROICexgc growth 5Y-6.25%
ROICexc growth 3Y1.11%
ROICexc growth 5Y-6.55%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Debt/EBITDA 5.96
Cap/Depr 234.56%
Cap/Sales 38.4%
Interest Coverage 2.33
Cash Conversion 115.87%
Profit Quality 107.66%
Current Ratio 1.81
Quick Ratio 1.66
Altman-Z 0.77
F-Score7
WACC5.06%
ROIC/WACC0.74
Cap/Depr(3y)212.07%
Cap/Depr(5y)195.52%
Cap/Sales(3y)33.77%
Cap/Sales(5y)31.75%
Profit Quality(3y)134.57%
Profit Quality(5y)187.54%
High Growth Momentum
Growth
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
EPS Next Y9.29%
EPS Next 2Y5.14%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%
Revenue Next Year-5%
Revenue Next 2Y-1%
Revenue Next 3Y0.61%
Revenue Next 5YN/A
EBIT growth 1Y25.67%
EBIT growth 3Y7.57%
EBIT growth 5Y-2.22%
EBIT Next Year409.03%
EBIT Next 3Y77.89%
EBIT Next 5YN/A
FCF growth 1Y1.09%
FCF growth 3Y-8.79%
FCF growth 5Y2.94%
OCF growth 1Y16.42%
OCF growth 3Y5.63%
OCF growth 5Y7.34%

ATCO LTD -CLASS I / ACO-X.CA FAQ

What is the ChartMill fundamental rating of ATCO LTD -CLASS I (ACO-X.CA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ACO-X.CA.


Can you provide the valuation status for ATCO LTD -CLASS I?

ChartMill assigns a valuation rating of 5 / 10 to ATCO LTD -CLASS I (ACO-X.CA). This can be considered as Fairly Valued.


How profitable is ATCO LTD -CLASS I (ACO-X.CA) stock?

ATCO LTD -CLASS I (ACO-X.CA) has a profitability rating of 4 / 10.


What is the valuation of ATCO LTD -CLASS I based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ATCO LTD -CLASS I (ACO-X.CA) is 12.24 and the Price/Book (PB) ratio is 1.31.


How financially healthy is ATCO LTD -CLASS I?

The financial health rating of ATCO LTD -CLASS I (ACO-X.CA) is 5 / 10.